Murray J. McAllister, PsyD
Murray J. McAllister, PsyD, is the executive director of the Institute for Chronic Pain (ICP). The ICP is an educational and public policy think tank. Its mission is to lead the field in making pain management more empirically supported. Additionally, the ICP provides Academic quality information on chronic pain that is approachable to patients and their families. Dr. McAllister is also the clinical director of pain services for Courage Kenny Rehabilitation Institute (CKRI), part of Allina Health, in Minneapolis, MN. Among other services, CKRI provides chronic pain rehabilitation services on a residential and outpatient basis.
"A community is a group of people banded together by gifts and stories."
It is embedded in our human history: stories. Even before modern day, numerous cultures have shared history lessons in the form of stories. By sharing wisdom and experiences, stories can build communities. In essence, individuals no longer feel alone; they feel a sense of belonging and connection. Those stories can generate emotion and help people cope with life's complexities.
On initial reaction, it might seem absurd to talk about the benefits of self-managing chronic pain without opioid medications. "What," one might ask, "would you use to reduce pain? You wouldn't want to live the rest of your life in pain, would you?" The topic seems absurd because pain reduction reflexively seems so important. Indeed, pain reduction from the use of opioids seems so important that it trumps everything else, even problems associated with the use of opioids.
What is irritable bowel syndrome?
Irritable Bowel Syndrome (IBS) is a common condition for which patients seek healthcare and the most common reason for a visit to a gastroenterologist. It affects at least 1 in 10 people and is considered the most common of the functional gastrointestinal disorders (FGIDs). The primary symptom is abdominal pain -- usually in the large intestine or stomach -- along with either constipation or diarrhea or both. The pain can be intense and constant, but often it fluctuates. Food moving through the intestines too quickly may result in diarrhea; too slowly, constipation. The gut may thus lose its normal rhythmicity.
The notion of a neuromatrix of the brain is a theoretical model that explains the nature of pain, including chronic pain. Ronald Melzack, PhD, a psychologist, and one of the founding fathers of the field of pain management as we know it today, developed the theory and published it in a series of papers at the end of the last century.1, 2, 3, 4 Melzack had previously revolutionized the field of pain management in an earlier theory that he had developed and published with his physician colleague, Patrick Wall, in what is known as the gate control theory of pain.5 Few theories in modern science have spawned more empirical research than those of the gate control theory of pain and the neuromatrix of pain. Indeed, while technically theories, the field largely considers these models as accurate explanations of the nature of pain, given the great wealth of empirical evidence that now confirms them. So, what is this notion of the neuromatrix of the brain that explains the nature of pain?
Few topics in healthcare generate more passion than the use of opioid medications for chronic, non-cancer pain. Some, in the debate, lead the charge for greater access to opioids, arguing fervently that these medications are under-prescribed, while others call for more limited access, arguing that opioids are over-prescribed. The central focus for these strong feelings is typically the issue of addiction, but other issues commonly receive attention as well, such as the effectiveness of opioids and humanitarian calls to alleviate suffering.
While it appears that the Affordable Care Act (ACA) may have slowed the rate of annual increases in health insurance premiums, the overall cost of health insurance continues to rise.1, 2, 3 Employers subsequently continue to face the dilemma of either absorbing these annual cost increases and thereby reduce potential profit or passing these costs onto their employees and thereby reduce their potential take-home pay. In other words, do you face the ire of shareholders or workers?
Chronic Pain Rehabilitation Programs
The American Chronic Pain Association provides information on chronic pain rehabilitation programs.
A TED Talk by Tracy Jackson, MD, of Vanderbilt University, on interdisciplinary chronic pain rehabilitation programs (aka, functional restoration programs).
Stigma is a significant and persistent problem for those with chronic pain. Stigma occurs when someone is judged for having a condition that they didn't choose to have, like chronic pain. In other words, stigma is the criticism of being bad in some way for simply having a condition that you didn't choose to have. It can also occur in relationship to how a patient with chronic pain is coping. Stigma thus arises when moral judgments occur not for wrong behavior, which might rightly get criticized, but for simply being who you are, for simply having the health condition that you have, or for how you are dealing with it.
One of the more common sentiments that chronic pain patients express is that that the profit-motive seems to have had too much of an influence on the recommendations that their healthcare providers have made over the years. After reflecting on all the years of chronic pain and all the years of failed treatments, many of which were tried again and again despite having failed to reduce pain at previous clinics, they conclude that the business side of healthcare has played too much of a role in their own care. They are now disappointed, angry, and distrustful of chronic pain management providers.
Patients with chronic pain, their healthcare providers, and society, more generally, are all typically concerned about addiction to opioid pain medications. This concern is well founded. Once commonly thought of as rare,1, 2 it is now generally accepted that the true rate of addiction to such medications is much higher than what was once thought.3, 4 The issue of addiction to prescription opioid pain medications generates considerable debate among the stakeholders in the field of chronic pain management. There are strong voices for the continued use of such medications despite the rate of addiction and strong voices against the continued use of these medications because of the rate of addiction.